Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Fixed Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   Fixed Capital/Sales(x) 0.760.820.890.620.48

What is the latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) is 0.76 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.76
Mar20240.82
Mar20230.89
Mar20220.62
Mar20130.48

How is Fixed Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.76
-7.32
Mar2024 0.82
-7.87
Mar2023 0.89
43.55
Mar2022 0.62
29.17
Mar2013 0.48 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Fixed Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹272.4 Cr -10.4% -15.2% -26.4% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,651.0 Cr 0.6% -3% -23% Stock Analytics
KAVERI SEED COMPANY ₹4,880.8 Cr -1.7% -6.7% 5.9% Stock Analytics
VENKYS (INDIA) ₹1,912.7 Cr -2% -12.5% -23.3% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,029.8 Cr -2.4% -14.5% -35.7% Stock Analytics
INDO US BIOTECH ₹257.2 Cr 2.2% -1.8% -49.9% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-10.4%

-15.2%

-26.4%

SENSEX

-0.6%

2.2%

5.3%


You may also like the below Video Courses